Champions Oncology Reports Quarterly Revenue of $7.6 Million
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/29/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- BioNTech ends colorectal cancer mRNA therapy trial early
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Needham sees mature node semiconductor strength in latest tracker
Champions Oncology (CSBR) Reports Q2 EPS of $0.03
December 16, 2019 4:10 PM ESTChampions Oncology (NASDAQ: CSBR) reported Q2 EPS of $0.03, versus $0.03 reported last year. Revenue for the quarter came in at $7.6 million, versus $6.7 million reported last year.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
... More